000			01762 a2200529 4500
005			20250515210816.0
264		0	_c20110531
008			201105s 0 0 eng d
022			_a1476-5365
024	7		_a10.1038/bmt.2010.38 _2doi
040			_aNLM _beng _cNLM
100	1		_aBlennow, O
245	0	0	_aRandomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT. _h[electronic resource]
260			_bBone marrow transplantation _cDec 2010
300			_a1710-8 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAmphotericin B _xtherapeutic use
650	0	4	_aAntifungal Agents _xtherapeutic use
650	0	4	_aAspergillosis _xdrug therapy
650	0	4	_aAspergillus _xgenetics
650	0	4	_aCandida _xgenetics
650	0	4	_aCandidiasis _xdrug therapy
650	0	4	_aChild
650	0	4	_aFemale
650	0	4	_aHematopoietic Stem Cell Transplantation _xadverse effects
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMycoses _xdrug therapy
650	0	4	_aPolymerase Chain Reaction _xmethods
650	0	4	_aProspective Studies
650	0	4	_aRisk Factors
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aRemberger, M
700	1		_aKlingspor, L
700	1		_aOmazic, B
700	1		_aFransson, K
700	1		_aLjungman, P
700	1		_aMattsson, J
700	1		_aRingdén, O
773	0		_tBone marrow transplantation _gvol. 45 _gno. 12 _gp. 1710-8
856	4	0	_uhttps://doi.org/10.1038/bmt.2010.38 _zAvailable from publisher's website
999			_c19558944 _d19558944